$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$162.64M
Market Cap
-
P/E Ratio
-1.06
EPS
$3.40
52 Week High
$0.87
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Alector, Inc. (ALEC) is a pioneering clinical-stage biopharmaceutical company engaged in the development of transformative therapies for neurodegenerative diseases, including Alzheimer's disease and frontotemporal dementia. Utilizing its proprietary immuno-neurology platform, Alector aims to leverage the immune system to restore neuronal health and function, positioning itself at the forefront of neurological innovation. Based in South San Francisco, the company boasts a promising pipeline of differentiated product candidates, poised to potentially reshape treatment paradigms and significantly improve patient outcomes in a field marked by high unmet medical need.
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
KVUE
ARTV
IREN
CLSK
MARA
PLTD
APLD
ORCL
DNN
SNAP
TLRY
NFLX
T
WULF
BTBT
VZ
RGTI
RKLB
BAC
PLTR
UBER
RIG
NIO
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
RR
MSTR
HBAN
MSFT
CPNG
VALE
CMG
CLYM
KDP
IONQ
NCLH
LPTX
WOK
MASK
NVDA
TSLA
ASST
IRBT
CGC
PLUG
AAL
ASBP
AVGO
IVP
PFE
LAZR
INTC
BITF
GRAB
BYND
F
WBD
ADAP
SOFI
CIFR
KVUE
ARTV
IREN
CLSK
MARA
PLTD
APLD
ORCL
DNN
SNAP
TLRY
NFLX
T
WULF
BTBT
VZ
RGTI
RKLB
BAC
PLTR
UBER
RIG
NIO
HPE
AMC
DVLT
QBTS
GOOGL
HOOD
SOUN
CAN
AMD
MU
PCG
RR
MSTR
HBAN
MSFT
CPNG
VALE
CMG
CLYM
KDP
IONQ
NCLH